Cyclacel Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)12holders
2famous investors
$2.09avg. 13F price*
At the end of Q1 2024, 12 institutions reported holding Cyclacel Pharmaceuticals Inc. in their 13F filings. The largest holders were Renaissance Technologies ($44K), Point72 Asset Management ($32K) and Acadian Asset Management LLC ($29K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Cyclacel Pharmaceuticals Inc.
- CUSIP
- 23254L801
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $10K |
| Exits | 3 | $101K |
Ownership 12 holders
| Renaissance Technologies | 0.00% | Add +44.3% | 20,838 | $44K |
| Point72 Asset Management | 0.00% | No change | 15,333 | $32K |
| Acadian Asset Management LLC | 0.00% | Reduce -41.0% | 14,285 | $29K |
| UBS Group AG | 0.00% | New | 4,835 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +419.0% | 4,188 | $9K |
| McIlrath & Eck, LLC | 0.00% | No change | 832 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 126 | $265 |
| Morgan Stanley | 0.00% | No change | 80 | $169 |
| Wells Fargo & Company | 0.00% | Add +2.6% | 40 | $85 |
| Signaturefd, LLC | 0.00% | No change | 20 | $42 |
| Harbour Investments, Inc. | 0.00% | No change | 13 | $27 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $6 |
"% of holder's portfolio" is CYCLACEL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Cyclacel Pharmaceuticals Inc. the manager owns.